Rafael Holdings RFL
NYSE RFL
$2.29 -0.14 (-5.76%)
As of: Sep 9, 2026 · 3:59 PM EDT

Rafael Holdings (RFL) Net Shares Issued and Repurchased (2020 - 2025)

Rafael Holdings' (RFL) quarterly Net Shares Issued and Repurchased came in at $24558.0 in Q4 2025, up 227.44% year-over-year from $7500.0 in Q4 2024, and down 93.78% quarter-over-quarter from $395000.0 in Q3 2025.

Analysis

Rafael Holdings (RFL) Net Shares Issued and Repurchased (2020 - 2025) Analysis & Trends

Rafael Holdings (RFL) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $24558.0 the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Net Shares Issued and Repurchased rose 227.44% year-over-year to $24558.0 in Q4 2025; TTM through Oct 2025 was $24558.0, a 227.44% increase from a year earlier, with the FY2025 full-year figure at $395000.0, up 58.0% from the prior year.
  • Net Shares Issued and Repurchased was $24558.0 for Q4 2025 at Rafael Holdings, down from $395000.0 in the prior quarter.
  • Over five years, Net Shares Issued and Repurchased peaked at $98.0 million in Q4 2021 and troughed at $7500.0 in Q4 2024.
  • A 5-year average of $16.6 million and a median of $273379.5 in 2023 frame the typical range for Net Shares Issued and Repurchased.
  • Across the five-year window, Net Shares Issued and Repurchased surged 4668789.95% in 2021 and slumped 99.96% in 2023, its largest moves.
  • Over 5 years, Net Shares Issued and Repurchased stood at $98.0 million in 2021, then changed by 0.0% to $98.0 million in 2022, then tumbled by 99.96% to $43878.0 in 2023, then sank by 82.91% to $7500.0 in 2024, then surged by 227.44% to $24558.0 in 2025.
  • The last three Net Shares Issued and Repurchased figures came in at $24558.0 (Q4 2025), $395000.0 (Q3 2025), and $7500.0 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Rafael Holdings 117.57 Mn 117.57 Mn 171,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2025 24,558.00
Jul 31, 2025 395,000.00
Oct 31, 2024 7,500.00
Jul 31, 2024 250,000.00
Oct 31, 2023 43,878.00
Jul 31, 2023 589,205.00
Jan 31, 2023 296,759.00
Oct 31, 2022 98.00 Mn
Jul 31, 2022 943,305.00
Oct 31, 2021 98.00 Mn
Jul 31, 2021 118,409.00
Apr 30, 2021 118,409.00
Oct 31, 2020 2,099.00
Jul 31, 2020 333.00